SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59%
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Operating Income Peer Comparison

Comparables:
E
EVT
GXI

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Operating Income
€171.2m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Operating Income
-€73.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Gerresheimer AG
XETRA:GXI
Operating Income
€210.2m
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
4%

See Also

What is SCHOTT Pharma AG & Co KgaA's Operating Income?
Operating Income
171.2m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Operating Income amounts to 171.2m EUR.

What is SCHOTT Pharma AG & Co KgaA's Operating Income growth rate?
Operating Income CAGR 3Y
23%

Over the last year, the Operating Income growth was 2%. The average annual Operating Income growth rates for SCHOTT Pharma AG & Co KgaA have been 23% over the past three years .

Back to Top